Lenoss Medical’s OsteoPearl procedure reached its 150th case, according to a March 27 news release shared with Becker’s. More than half of the 150 cases were completed since September. OsteoPearl is ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

We forecast WuXi's revenue growth to be slower than that of other well-established peers. The risk is high that the US Biosecure Act will become law, and we expect global pharmaceutical or ...

If your eczema is severe enough to warrant the use of a biologic, then you’ll most likely need lifelong treatment. There’s no cure for eczema. Most people with eczema benefit from the ...

The approval of new oral medications and biologic therapies has greatly improved the ability to manage this chronic condition that is often refractory (meaning it does not respond well to treatment).

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN DIEGO -- Novel ultra-long-acting biologic depemokimab reduced nasal polyps in chronic rhinosinusitis, two parallel ...